Chief Executive Officer
Mr Brett Carter
Brett joined Cancer Therapeutics CRC as Chief Operating Officer in March 2017. He has nearly 20 years of pharmaceutical industry experience with broad exposure across the medicine discovery, development and commercialisation lifecycle, having held roles in research & development, manufacturing & supply and business development.
Brett worked at GSK for 11 years, initially in Product Development and later in Business Development, where he led worldwide licensing, acquisition and venture capital backed business development transactions. Prior to joining GSK, Brett worked as a chemist and as a management consultant. Brett is a former Chair of the Global Health Investment Fund Limited Partner Advisory Committee, he has a BSc in Applied Chemistry from RMIT University Melbourne, and an MBA from London Business School.